Annual Survival Rate Statistics Update—Multiple Myeloma Rate Unchanged
New data—based solely on observation—from the United States National Cancer Institute’s Surveillance, Epidemiology, and End Results shows that the survival…
Caregiving For A Loved One—What You Should Know
When a loved one is diagnosed with myeloma (or really any chronic disease), the feeling of shock is overwhelming. There…
Our Next Show: Quad Treatment with Transplant for Newly Diagnosed Myeloma with Luciano Costa, MD, PhD University of Alabama
Monday, April 16, 2018 @ 10 am Pacific, 11 am Mountain, Noon Central, 1:00 pm Eastern Call In by Phone…
Full Show: NAM-Natural Killer Cells with Elotuzumab by Viktoria Bachanova, MD, PhD, University of Minnesota
Viktoria Bachanova, MD, PhD University of Minnesota Interview Date: March 12, 2018 Summary Natural killer cells are the body’s way…
Our Next Show: Quad Treatment with Transplant for Newly Diagnosed Myeloma with Luciano Costa, MD, PhD University of Alabama
Monday, April 16, 2018 @ 10 am Pacific, 11 am Mountain, Noon Central, 1:00 pm Eastern Call In by Phone…
Clinical Trial: New Takeda CD-38 Monoclonal Antibody (Subcutaneous) For Relapsed/Refractory Myeloma
A Phase I and IIa study is open to test the safety and impact on myeloma for a new monoclonal…
Upcoming Myeloma Crowd Roundtables
Upcoming Myeloma Crowd Events
We Did it! Together, Patients and Experts Helped the Myeloma Crowd Research Initiative Exceed Our $500,000 Goal for High Risk Myeloma Research
In 2015 the Myeloma Crowd had a hypothesis: If patients collaborated with myeloma experts, we could accelerate a cure. Our…
Continuing the Fight for a Myeloma Cure: Dr. Tricot and Dr. Zhan’s Research to Improve Outcomes for High-Risk Myeloma Patients
Guido Tricot, MD, PhD has devotedly attended to thousands of multiple myeloma patients for over two decades. His tandem autologous…
Thanks to our site sponsors:
